More About Us!

>> We recently updated our brochure about Highland Ophthalmology Vision Care Facility in New Windsor. Click here to view and print a copy!


ARTICLES

>> Article Written by Dr. Mary Davidian "Amniotic Membrane For Ocular Inflammation" Ophthalmology Management, June 1, 2013


NEWS


>>
Highland Ophthalmology Associates Offering New FDA-Approved Avedro Corneal Collagen Cross-Linking Procedure to Keratoconus Patients

>>
Highland Ophthalmology Establishes a Dry Eye Center of Excellence in the Hudson Valley of New York

>> Medical Eye Specialist Dr. Julia Mathews Joins New Windsor, New York Practice Highland Ophthalmology

>>
Highland Ophthalmology Introduces LipiFlow to Address Dry Eye Syndrome Caused by MGD

>>
Medical Eye Specialist Dr. Michael Stagner Joins New Windsor, New York Practice Highland Ophthalmology

>> Dr. Mary Davidian to Appear on American Health Front Program on NBC

>> Need for Eye Surgery Lessened by New Corneal Wound and Healing Treament

>> Highland Ophthalmology Opens New State-of-the-Art Vision Center

>> Highland Ophthalmology Celebrates Grand Opening of New Vision Center in New Windsor

>> Newburgh Ophthalmologists Offer Free Glaucoma Screenings Jan. 24

>> High-Tech Eye Care Right Here at Home

>> Eye Doctors Urge Exams During Glaucoma Awareness Month

>> Glaucoma Specialist Joins New Windsor, NY Ophthalmology Practice

>> New Windsor, NY Eye Surgeon Offers Alcon’s AcrySof® ReSTOR® Intraocular Lens for Cataract Correction

>> Alcon Launches AcrySof® ReSTOR® Apodized Diffractive IOL; Revolutionary Apodized Diffractive Technology Provides Highest Level of Freedom from Glasses

>> CMS Ruling Provides Medicare Patients Access to Alcon’s AcrySof® ReSTOR® IOL

 


Latest Press Releases

For Immediate Release

Highland Ophthalmology Associates Offering New FDA-Approved Avedro Corneal Collagen Cross-Linking Procedure to Keratoconus Patients

New Windsor, New York, January 20, 2017 – Highland Ophthalmology Associates, LLC (www.highlandophthalmology.com), a leading specialty eye care center in New Windsor, New York, announced today that it is now providing a new FDA-approved procedure, Avedro Corneal Collagen Cross-Linking, to patients who suffer from Keratoconus.


Keratoconus, often referred to as "KC", is an eye condition in which the cornea weakens and thins over time, causing the development of a cone-like bulge and optical irregularity of the cornea. Though a rare condition, keratoconus typically first appears in individuals who are in their late teens or early twenties. It can result in significant visual loss and, in severe cases, may require corneal transplant surgery to help restore vision.


As corneal specialists who have been involved in the care of many Keratoconus patients over the years, Dr. Mary Davidian and Dr. Julia Mathew of Highland Ophthalmology Associates are excited to be able to make use of this new technology. For patients, it offers the hope of possibly being able to avoid major corneal transplant surgery and maintain good visual acuity through implementation of this 1 hour, out-patient procedure.


The corneal collagen cross-linking procedure stiffens corneas that have been weakened and, in many cases, helps halt progression of the Keratoconus disease process, allowing good vision to be maintained. The procedure involves applying numbing drops to the eye and then gently removing the surface layer of the cornea. Next, Photrexa® Viscous drops are applied to the eye over a 30-minute period. The cornea is then exposed to UV light with the use of the Avedro KXL® System for 30 minutes, while additional Photrexa® Viscous drops are applied. The patient returns home with a bandage contact lens in place to help with discomfort and is monitored by their Highland Ophthalmology eye surgeon over the next few weeks.


Currently, the Avedro KXL® System with the Photrexa® Viscous drops is the first and only FDA-approved corneal collagen cross-linking treatment available in the United States. As corneal specialists, the doctors at Highland Ophthalmology are fully certified to offer this latest treatment to Keratoconus patients.


For more information about corneal collagen cross-linking and Keratoconus, contact Highland Ophthalmology Associates by calling 845-562-0138 or visit www.highlandophthalmology.com.

 

For Immediate Release

Highland Ophthalmology Establishes a Dry Eye Center of Excellence in the Hudson Valley of New York

New Windsor, New York, September 27, 2016 – Highland Ophthalmology Associates, LLC (www.highlandophthalmology.com), a leading specialty eye care center, announced today the establishment of a Dry Eye Center of Excellence at its state-of-the-art eye care facility in New Windsor, New York. The Dry Eye Center of Excellence offers patients a comprehensive array of advanced, proven technologies to diagnose and treat chronic Dry Eye Syndrome.

It is estimated more than 23 million people over the age of 20 suffer from chronic dry eye. In many cases, the root cause is Meibomian Gland Dysfunction (MGD), also known as Evaporative Dry Eye. The condition occurs when the Meibomian glands, which are responsible for producing the oil layer in tears, do not function properly. “Chronic Dry Eye Syndrome must be properly diagnosed and managed. If left untreated, chronic dry eye often becomes so uncomfortable that patients must make lifestyle adjustments and it can impact one’s vision and eye health,” said Dr. Mary Davidian, Founder and Medical Director of Highland Ophthalmology.

The suite of innovative solutions utilized by the eye care team at Highland Ophthalmology includes LipiView®, LipiFlow®, ProKera® and Prokera Clear, Avenova and HydroEye® to name a few.

Thorough Evaluation

Patients reporting acute symptoms of dry eye are evaluated first with a thorough slit lamp examination, and then by using state-of-the-art diagnostic LipiView® technology. This non-invasive imaging procedure, which takes less than five minutes, captures detailed images of the tear film to identify any gland blockage and atrophy and allows doctors to determine if a patient exhibits Meibomian Gland Dysfunction.

Innovative Technology

Highland Ophthalmology is the first practice in the New Windsor area to offer LipiFlow®, a new, breakthrough system for assessing and treating Evaporative Dry Eye. While many traditional dry eye treatment options like warm compresses, eye drops and ointments have been available for years, they do not address the root cause of the condition. Many of these treatments have been proven ineffective in providing relief for some patients. The revolutionary LipiFlow® system uses warm heat and pressure to unblock Meibomian glands, allowing tears to comfort the eye and provide relief. This in-office procedure takes less than 15 minutes and relieves symptoms for up to 12 months. It is rapidly becoming the new standard of care for treating the cause and not just the effects of chronic dry eye.

ProKera® is a biologic corneal bandage lens containing amniotic membrane tissue that is the only FDA cleared therapeutic medical device that reduces inflammation and promotes ocular healing. Since dry eye disease is often inflammatory in etiology, this unique device has proven to be markedly beneficial in providing ocular comfort to patients who are currently using multiple treatment modalities, but are still suffering from symptoms of dryness. More recently, the Biotissue Company has introduced the Prokera Clear which allows for maintenance of the patient’s vision during treatment, due to the presence of the central Clear-View Aperture. Prokera Clear® is ideal for ambulatory, chronic ocular surface disease, corneal-involved dry eye patients, and post Lasik/PRK patients. Sutureless and adhesiveless, ProKera® is a safe and effective method to promote healing and reconstruction of the ocular surface and orbit with minimal side effects.

HydroEye® is a patented nutritional formulation that works from the inside out to provide continuous support for dry eyes. HydroEye®, the focus of new research, delivers a proprietary blend of omega fatty acids (GLA, EPA and DHA), antioxidants and other key nutrients that work together to support a healthy tear film and soothe the ocular surface.

Avenova® with Neutrox® is the only non-detergent based, prescription eyelid and lash hygiene product containing pure hypochlorous acid, an active antibacterial, antifungal and virucidal compound. In addition, it exhibits anti-inflammatory activity by neutralizing inflammatory mediators in the body. By effectively treating eyelid inflammation, Avenova is an essential part of our treatment armamentarium helping to address the multifactorial etiology of Dry Eye Disease.

Team of Specialists

Patients at Highland Ophthalmology can take confidence in knowing their vision needs will be addressed by well-trained, dedicated physicians and specialists. Each patient’s unique needs are carefully evaluated using the most advanced testing equipment in order to develop a customized treatment plan.

Advancing Knowledge in our Community

The Center’s reputation for excellence is also underscored by the number of eye care practitioners who refer their advanced Dry Eye Patients to our group of specialists. Through this collaboration, local doctors have the advanced knowledge needed to help their patients and guide them on the advanced treatment options now available.

More information about the Dry Eye Center of Excellence and the services provided by Highland Ophthalmology is available at www.highlandophthalmology.com.

 

For Immediate Release

Medical Eye Specialist Dr. Julia Mathew Joins New Windsor, New York Practice Highland Ophthalmology

New Windsor, New York, July 18, 2016 – Highland Ophthalmology Associates, LLC (www.highlandophthalmology.com), a leading specialty eye care center in New Windsor, New York, announced today that Julia Mathew, M.D. has joined their group of cataract eye surgeons, cornea and glaucoma specialists, and optometrists.


Dr. Mathew is an ophthalmologist and cornea specialist and surgeon. She recently completed her Cornea Fellowship at the New York Eye and Ear Infirmary of Mount Sinai in New York, New York with Dr. John Seedor and Dr. David Ritterband, who are world renowned Cornea specialists.


She earned her Doctor of Medicine degree from Albany Medical College in Albany, New York, and performed her medical internship at NSLIJ-Lenox Hill Hospital in New York, New York prior to completing her residency in ophthalmology at the New York Eye and Ear Infirmary of Mount Sinai in New York, New York.


Dr. Mathew originally received her bachelor of science degree in biology and sociology and completed post-graduate studies in Clinical Leadership in Health Management from Union College, Schenectady, New York.


“We feel very fortunate to have a doctor, with the extensive training in cornea surgery that Dr. Mathew has, join our eye surgeons and staff here at Highland Ophthalmology. We operate in an 8,000 square foot, state-of-the-art specialty eye care center, with twelve exam lanes, eight diagnostic rooms equipped with the latest in ocular imaging and testing devices, and an expanded optical shop. Dr. Mathew will join myself, Dr. Tim Huynh, Dr. Michael Stagner and Dr. Sharon Powell to provide the highest level of specialty eye care to patients in our community,” said Dr. Mary Davidian, Founder and Medical Director of Highland Ophthalmology Associates.


Dr. Julia Mathew is a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology and the American Society of Cataract and Refractive Surgery.


More information about Julia Mathew, M.D. and the services provided by Highland Ophthalmology is available at www.highlandophthalmology.com.

 

For Immediate Release

Highland Ophthalmology Introduces LipiFlow to Address Dry Eye Syndrome Caused by Meibomian Gland Dysfunction

FDA-Cleared LipiFlow Treatment Safely, Effectively Treats Root Cause of Dry Eye Disease

New Windsor, New York, June 23, 2016 – Highland Ophthalmology Associates, LLC (www.highlandophthalmology.com), a leading eye specialty center in the Hudson Valley of New York, announced today that it is now providing a revolutionary new treatment, LipiFlow®, for patients who suffer from dry eye caused by Meibomian Gland Dysfunction (MGD). MGD, a progressive disease that affects some 300 million people worldwide, stems from blockages in the oil-producing meibomian glands located in the eyelids. LipiFlow unblocks the glands, allowing the glands to resume the secretion of oily lipids needed for a healthy tear film.


Developed as a result of 30 years of scientific research, LipiFlow is an in-office procedure that uses directed heat and gentle pressure to liquefy and express the contents of meibomian glands. This revolutionary treatment is FDA-cleared and scientifically proven. In a clinical study, 90 percent of patients achieved improvements in gland secretions after a single LipiFlow treatment.


MGD can negatively impact long term vision and ocular health. If left untreated, MGD will worsen over time, leading to eye redness, dryness, irritation, burning, and eye fatigue. These symptoms can hinder daily activities such as reading, using the computer, wearing contact lenses, and being outdoors on windy days. Patients who suffer from these symptoms should be screened for MGD as part of their routine comprehensive eye examination. Early identification of MGD can yield the best results for long term ocular health.


"Dry eye disease is one of the chief complaints that I hear from patients," said Dr. Mary Davidian, Founder and Medical Director of Highland Ophthalmology Associates, LLC. "We are pleased to introduce LipiFlow for patients who are frustrated with all the ways that MGD negatively impacts their lives. Conventional therapies, such as warm compresses, over-the-counter wetting drops, ointments, and prescription drugs have failed to provide the relief that LipiFlow offers. LipiFlow is a safe and painless treatment that is the most effective treatment for MGD available today."


Patients who suffer from dry eye caused by MGD are urged to contact Highland Ophthalmology Associates. Dr. Davidian Dr. Huynh, Dr. Stagner, Dr. Mathew and Dr. Powell are currently offering this novel treatment to existing and new patients at Highland Ophthalmology.


For more information about the LipiFlow and other Dry Eye treatments, please visit www.highlandophthalmology.com. Call (845) 562-0138 today to make an appointment for a consultation.

 

For Immediate Release

Medical Eye Specialist Dr. Michael Stagner Joins New Windsor, New York Practice Highland Ophthalmology

New Windsor, New York, May 16, 2016 – Highland Ophthalmology Associates, LLC (http://www.highlandophthalmology.com), a leading specialty eye care center in New Windsor, New York, announced today that Dr. Michael J. Stagner, M.D. has joined their group of cataract eye surgeons, cornea and glaucoma specialists, and optometrists.


Dr. Stagner is a highly experienced anterior segment eye surgeon who has performed thousands of cataract surgeries and is proficient in glaucoma treatment and management, medical retina treatment, and all general aspects of medical ophthalmology. He earned his Doctor of Medicine degree from Creighton University School of Medicine in Omaha, Nebraska, and performed his medical internship at the Good Samaritan Hospital in Portland, Oregon prior to completing his residency in ophthalmology at the Oregon Health Sciences University.


Dr. Stagner’s medical career in ophthalmology began at the San Luis Valley Medical Clinic in Alamosa, Colorado and continued through operating his private practice, Stagner Eye Center, in Kingman, AZ. Relocating to the Hudson Valley of New York, Dr. Stagner brings his 22 years of experience to Highland Ophthalmology, assisting as a diagnostician for the analysis and treatment of varied eye conditions and as a patient educator.


Dr. Stagner originally received his bachelor of science degree in chemical engineering from Wayne State University in Detroit, Michigan. He subsequently did post-graduate studies in anthropology, biochemistry and education at The University of Wyoming. He initially worked as an engineer for Exxon and The Department of Energy before making the decision to attend Medical School.


“We feel very fortunate to have a doctor, with the extensive experience and caliber of achievements that Dr. Stagner has, join our eye surgeons and staff here at Highland Ophthalmology. We operate in an 8,000 square foot, state-of-the-art specialty eye care center, with twelve exam lanes, eight diagnostic rooms equipped with the latest in ocular imaging and testing devices, and an expanded optical shop. Dr. Stagner will join myself, Dr. Tim Huynh and Dr. Sharon Powell to provide the highest level of specialty eye care to patients in our community,” said Dr. Mary Davidian, Founder and Medical Director of Highland Ophthalmology Associates.


Dr. Mary Davidian has been residing in and serving the greater Hudson Valley community since 1997 when she founded Highland Ophthalmology Associates.


Dr. Stagner is Board Certified by the American Board of Ophthalmology and a member of the American Academy of Ophthalmology, to which he was elected a Fellow in 1995.


More information about Dr. Michael Stagner, M.D. and the services provided by Highland Ophthalmology is available at www.highlandophthalmology.com.

 

For Immediate Release

Dr. Mary Davidian to Appear on American Health Front Program on NBC

Local Ophthalmologist and Eye Surgeon will discuss unique corneal wound repair and healing device called ProKera® on June 24, 2012 at 12:30 PM

New Windsor, New York, June 15, 2012 – Mary Davidian, M.D., of Highland Ophthalmology Associates, a leading eye surgeon in The Hudson Valley, has been invited by "AMERICAN HEALTH FRONT!" to present the latest developments in corneal eye wound treatment. Dr. Davidian will be discussing her experiences using a unique alternative to surgery for corneal wound repair and healing called ProKera®. This segment of "AMERICAN HEALTH FRONT!", a medical news television program designed to educate viewers about important advances in medical techniques and technologies, will air on Sunday, June 24th, 2012 at 12:30 p.m. eastern standard time on NBC TV.


Considered a leading expert in cataract and corneal transplant surgery, Dr. Davidian will explain the functions of ProKera®, a medical device that can provide wound repair and healing to patients afflicted with a damaged cornea that does not require surgery. In a recent interview Dr. Davidian summed up the advantages of ProKera® as an exceptional alternative to surgery since it provides patients with a faster and less painful recovery from most corneal wounds.


Dr. Mary Davidian, founder and Medical Director of Highland Ophthalmology Associates, LLC, has been living in and serving the greater Hudson Valley community for the past fifteen years. Dr. Davidian is a fellowship trained corneal specialist. She is a member of the American Academy of Ophthalmology (AAO), the American Society of Cataract and Refractive Surgery (ASCRS), the New York Keratorefractive Surgery Society, the New York Intraocular Lens Implant (NYIOL) Society, and the New York State Ophthalmological Society (NYSOS) in which she has served on the Board of Directors.

Dr. Davidian is board certified by the American Board of Ophthalmology and serves as an Associate Adjunct Professor at the New York Eye and Ear Infirmary and the New York Medical College.


For further information please contact Highland Ophthalmology Associates at (845) 562-0138 or visit www.highlandophthalmology.com.


For more information about Bio-Tissue ProKera® visit www.biotissue.com.

ProKera® is a registered trademark of Bio-Tissue, Inc.

 

For Immediate Release

Need for Eye Surgery Lessened by New Corneal Wound and Healing Treatment

Highland Ophthalmology Associates Offers ProKera® to Corneal Patients

New Windsor, New York, February 14, 2012 – Mary Davidian, M.D., of Highland Ophthalmology Associates, a leading eye surgeon in The Hudson Valley, announces  offering her patients a unique corneal wound repair and healing device called ProKera®.  Today, ProKera® is the only medical device that can provide wound healing to patients afflicted with a damaged cornea, the outer transparent surface of the eye.

ProKera® is a unique treatment option for patients presenting with corneal abrasions, scarring, erosions, corneal scars, chemical burns, corneal defects, partial limbal stem cell deficiencies, high-risk corneal transplants, Stevens - Johnson syndrome, and many other ocular surface conditions which may require corneal surgery or a corneal transplant. Sutureless and adhesiveless, ProKera® is a safe and effective method to promote healing and reconstruction of the ocular surface and orbit with minimal side effects.  

ProKera® is similar to a contact lens and is made by placing a piece of amniotic membrane tissue in between two rings made out of a clear, flexible material.  The membrane is thin and clear, like the tissue on the surface of the eye, and protects the eye's damaged tissue while inserted. The ProKera® device can remain in the eye for up to 30 days. However, it should facilitate healing of most defects within 5-10 days, at which point the membrane in the device will naturally dissolve and the ring set can be removed by an eye surgeon.

The healing properties of ProKera® deliver natural biological and therapeutic actions inherent in amniotic tissue to help damaged eye surfaces heal faster. Eyes treated with ProKera® heal faster, with less scarring and inflammation.  Moreover, it reduces chances of the formation of abnormal blood vessels, and induces less pain or discomfort to the patient.

"ProKera® allows me to provide my patients with exceptional clinical results safely and effectively, without surgery," said Dr. Mary Davidian. "In addition, the ProKera® device is now configured and packaged much like a contact lens, which enables easy insertion right here in our office, hospital bedside, or following other surgical procedures. I have been using ProKera® in the operating room for several years and I was delighted when it was officially approved by Medicare recently for use as an office procedure rather than an operating room procedure."

Considered a leading expert in cataract, corneal treatment and surgery, Dr. Davidian frequents national conferences on ophthalmology. She has lectured to other ophthalmologists on the proper use of ProKera®, proper diagnosis, and addressing the conditions under which a patient can benefit the most from this device.

"I think of it as a magic bandaid," said Dr. Davidian. "As a corneal specialist, I see a lot of patients with corneal damage, including patients referred to me by my colleagues. ProKera® allows me to provide patients with a unique alternative to surgery which, in many cases, helps them with a much quicker and less painful recovery."

Dr. Mary Davidian, founder and Medical Director of Highland Ophthalmology Associates, LLC, has been living in and serving the greater Hudson Valley community since 1997. Dr. Davidian is a fellowship trained corneal specialist.  She is a member of the American Academy of Ophthalmology (AAO), The American Society of Cataract and Refractive Surgery (ASCRS), the New York Keratorefractive Surgery Society, the New York Intraocular Lens Implant (NYIOL) Society, and the New York State Ophthalmological Society (NYSOS) in which she has served on the Board of Directors.

Dr. Davidian is board certified by the American Board of Ophthalmology and serves as an Associate Adjunct Professor at the New York Eye and Ear Infirmary and the New York Medical College.

For more information about ProKera®, ask your doctor or visit www.highlandophthalmology.com.

The Bio-Tissue ProKera® website is
www.biotissue.com.

Call (845) 562-0138 today for your first consultation with Dr. Davidian.

ProKera® is a registered trademark of Bio-Tissue, Inc.


For Immediate Release

Highland Ophthalmology Celebrates Grand Opening of New Vision Center in New Windsor

New Windsor, New York (PRWEB) June 22, 2009 – Highland Ophthalmology Associates, LLC will host the grand opening of its new eye care facility in New Windsor, New York. The new 6,000 square foot, state-of-the-art specialty eye care center features nine exam lanes, six diagnostic rooms equipped with the latest in ocular imaging and testing equipment, and an expanded optical shop. Staffed with four physicians and a dedicated staff, the contemporary facility provides the highest level of eye care to its patients. "We have always strived to provide the highest level of sub-specialty eye care to patients of our community," said Dr. Mary Davidian, Founder and Medical Director of Highland Ophthalmology Associates.

The grand opening and ribbon cutting ceremony is scheduled at 12 noon on Thursday, June 25th, 2009.

Highland Ophthalmology Associates conveniently accommodates local residents that require specialty eye care services. Through the expertise of board-certified medical eye doctors, it provides the latest in eye exams, diagnostics, and prescription eyewear, along with advanced cataract, corneal transplant and glaucoma surgeries. Patients no longer have to travel far distances to receive these specialty services. "In the past, patients needing specialty eye care services had to be referred to physicians in New York City or Albany, since access to Fellowship Trained Cornea and Glaucoma Surgeons was not available locally," said Dr. Thien Huynh, Glaucoma Specialist at Highland Ophthalmology. "Patients not only had to travel far distances for their surgeries, but also had to continue to travel far for their follow up care."

Dr. Mary Davidian and Dr. Thien (Tim) Huynh are board-certified ophthalmologists, medical doctors who are specially trained to provide a wide spectrum of eye care, from prescribing glasses and contact lenses to complex and delicate eye surgery. Having completed a Cornea Fellowship at the University of California at Irvine after her residency training at the New York Eye and Ear Infirmary in Manhattan, Dr. Davidian has worked closely with Dr. Richard Mackool, one of the innovators of modern day cataract surgery. She is a member of the American Academy of Ophthalmology (AAO), The American Society of Cataract and Refractive Surgery (ASCRS), the New York Keratorefractive Surgery Society, the New York Intraocular Lens Implant (NYIOL) Society, and the New York State Ophthalmological Society (NYSOS) in which she has served on the Board of Directors. She is board certified by the American Board of Ophthalmology and serves as an Associate Clinical Professor of Ophthalmology at the New York Eye and Ear Infirmary and New York Medical College, where she is actively involved with resident education.

Dr. Thien (Tim) Huynh received his fellowship training in Glaucoma at the Mount Sinai School of Medicine in New York City and brings this unique expertise to the community. He earned his medical degree from NYU School of Medicine and performed his medical internship at St. Luke's Roosevelt Hospital in New York City before completing a residency in ophthalmology at Drexel University's College of Medicine in Philadelphia. He is board certified by the American Board of Ophthalmology and a Magna Cum Laude graduate from Harvard University.

Dr. Miriam Rolf and Dr. Maureen Wallen are optometrists who practice general eye care and conduct contact lens fittings. Together, the doctors and staff at Highland Ophthalmology are able to provide patients with their complete eye care needs.

The new office of Highland Ophthalmology Associates is conveniently located at 140 Executive Drive, New Windsor, NY 12553.

For information about the grand opening event, please contact Nancy Ingersoll at (845) 562-0138.


For Immediate Release

Eye Doctors Urge Exams During Glaucoma Awareness Month

Highland Ophthalmology Associates to Offer Free Glaucoma Screenings

Newburgh, New York January 2, 2007 – In honor of Glaucoma Awareness Month, Highland Ophthalmology Associates, in Newburgh, NY, will be offering free Glaucoma Screenings on Saturday, January 13, 2007. Highland Ophthalmology Associates encourages anyone at risk to please participate in their Glaucoma Awareness Program.

It is estimated that over 3 million Americans have glaucoma and half are at risk for going blind because they remain undiagnosed. "Glaucoma is a complex disease, because there are no symptoms in the early stages.  By the time vision loss is noted by the patient, the disease process is quite advanced.  If detected early enough, vision loss from glaucoma can be treated and prevented,” said Dr. Tim Huynh an Eye M.D. and a fellowship trained glaucoma specialist at Highland Ophthalmology. "As part of Glaucoma Awareness Month in January, we are urging people who might be at risk to come to our office for a free Glaucoma Screening."

“Who is at risk?  African-Americans have a higher incidence of glaucoma, and it often appears at a younger age than in other racial groups. Anyone with a close relative - father, mother or sibling - with glaucoma is also at risk. Older people, those with diabetes and people who have had a serious eye injury are considered at risk as well" says Dr. Huynh.  “Anyone who falls into these groups should call us or their Eye M.D. to have their eyes examined. Although glaucoma cannot be cured, early detection and treatment can usually preserve vision.”

Glaucoma is a condition in which the optic nerve, responsible for transmitting visual information from the eye to the brain, is damaged. It can be associated with elevated pressure within the eye and often leads to vision loss. It begins with the loss of peripheral vision and then advances to a reduction in central vision. Glaucoma can potentially lead to blindness.

On Saturday January 13, 2007, Highland Ophthalmology will be hosting complimentary glaucoma screenings at their office between the hours of 9:00 AM and 12:30 PM. Walk-ins are welcome but appointments can be scheduled to help minimize wait time by calling (845) 562-0138.


For Immediate Release

Glaucoma Specialist Joins NewNewburgh, NY Ophthalmology Practice

Newburgh, NY - July 10, 2006 - Thien (Tim) Huynh, M.D. has joined Highland Ophthalmology Associates in Newburgh, NY where he will practice glaucoma as well as general ophthalmology.

Dr. Huynh is a Fellowship Trained Glaucoma Specialist who brings this unique expertise to our community. He earned his medical degree from NYU School of Medicine. He performed his medical internship at St. Luke's Roosevelt Hospital, in New York, NY before completing a four year residency in ophthalmology at the Drexel University College of Medicine, in Philadelphia, Pennsylvania. He then continued on to receive his fellowship training in glaucoma at the Mount Sinai School of Medicine in New York.

Glaucoma is a disorder associated with pressure in the eye, and is characterized by damage to the optic nerve. Glaucoma affects 2 million Americans, and half of those people are unaware they have the disease. Glaucoma is much more complex than most patients would like to believe. This very fact is the reason that glaucoma sub-specialist ophthalmologists have an additional one to two years of fellowship training beyond the four years of general ophthalmology residency training.

Dr. Huynh is a member of the American Academy of Ophthalmology (AAO), the American Medical Association (AMA), and the New York State Ophthalmological Society (NYSOS).


For Immediate Release

Newburgh, NY Eye Surgeon Offers Alcon’s AcrySof® ReSTOR® Intraocular Lens for Cataract Correction

Newburgh, New York – June 14, 2005 – Mary Davidian, M.D., of Highland Ophthalmology Associates, a leading ophthalmic surgeon in Newburgh, announces the offering of Alcon’s AcrySof® ReSTOR® Intraocular Lens (IOL) for cataract patients.

The AcrySof ReSTOR lens is a foldable IOL that represents breakthrough technology because of its unique, patented optic design, which allows patients to experience the highest level of freedom from glasses ever achieved in IOL clinical trials. The AcrySof ReSTOR IOL uses a combination of three complementary technologies: apodization, diffraction and refraction, to allow patients to experience a full range of high-quality vision without the need for reading glasses or bifocals. The benefit for patients is a high level of spectacle freedom.

Dr. Davidian has been using the earlier generation of the Alcon AcrySof lens for many years to correct cataract patients distance vision. "With the new ReSTOR lens, we can now offer our patients the ability to see clearly at near, intermediate and distance vision", said Dr. Davidian.

Ideal candidates for the ReSTOR lens are those patients over 50 who need both distance correction and reading glasses, bifocals/trifocals, or progressive lenses, or those who have cataracts. The ReSTOR lens has been used with great success in Europe for the last two years, but just received FDA approval for use in the United States. The regular AcrySof lenses, manufactured by Alcon, have been used in the US since 1990, and are the most frequently implanted lens in the US. To date, more than 21 million AcrySof lenses have been placed. In the US clinical trials more than 80% of patients who had placement of the ReSTOR lens NEVER wore glasses after the surgery. 94% were able to read the newspaper and drive without glasses.




Our office is within an easy commute from the following areas in the Hudson Valley and Orange County and Dutchess County: New Windsor, Cornwall, Fishkill, Middletown, Florida, Warwick, Monroe, Harriman, Fort Montgomery, Highland Falls, Marlboro, Walden, Wallkill, Pine Bush, Vails Gate, Goshen, Salisbury Mills, Washingtonville, Campbell Hall, Montgomery, West Point, Modena, New Paltz, Highland, Beacon, Castle Point, Wappingers Falls, Poughkeepsie, NY.

With this, Highland Ophthalmology has become New Windsor's leading specialty eye care center. Call (845) 562-0138 today for your first consultation.

 




Highland Ophthalmology Associates on LinkedIn

     | 

 


To expedite your visit to Highland Ophthalmology please download and complete a New Patient Information Form prior to your first visit and present it to the receptionist when checking in:

Contact Us

Call us at (845) 562-0138 or fill out and submit this form to learn more about Highland Ophthalmology.

Please Note: Do not use this form for emergency purposes.

Name:*
Email:*
Phone:*
Comments:
* Required Fields

I agree to the Terms of Use
and Privacy Policy.


By checking the box, you are indicating that you have read, understand and consent to Highland Ophthalmology Associates Terms of Use and Privacy Policy.

 



AcrySof® IQ Toric IOLs

 


AcrySof® IQ ReSTOR® IOLs

 



PROKERA®

 


 


 

 

TearLab® Osmolarity System

 



Copyright © 2017
Highland Ophthalmology Associates, LLC.
All rights reserved.

140 Executive Drive
New Windsor, NY 12553

Telephone (845) 562-0138
Fax (845) 562-0147

To see a map of our location and get directions, click here.

   
About HOA Procedures

Dr. Mary Davidian
Dr. Thien Huynh
Dr. Julia Mathew
Dr. Michael Stagner
Dr. Sharon Bean Powell

Cataract Treatment
Corneal Transplants
Glaucoma Treatment
Dry Eye Treatment